HomeKYTX • NASDAQ
Kyverna Therapeutics Inc
add
$2.50
8.70%
After Hours:(4.40%)+0.11
$2.61
Closed: Mar 26, 6:11:42 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.88M | 198.60% |
Net income | -34.49M | -123.03% |
Net profit margin | — | — |
Earnings per share | -0.80 | — |
EBITDA | -36.75M | -128.69% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 321.59M | 316.16% |
Total assets | 339.20M | 266.75% |
Total liabilities | 36.49M | 53.83% |
Total equity | 302.71M | — |
Shares outstanding | 43.17M | — |
Price to book | 0.33 | — |
Return on assets | -26.39% | — |
Return on capital | -28.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -34.49M | -123.03% |
Cash from operations | -27.49M | -146.94% |
Cash from investing | 676.00K | 101.25% |
Cash from financing | -152.00K | -100.44% |
Net change in cash | -26.97M | 11.47% |
Free cash flow | -13.07M | — |
Previous close
$2.30
Day range
$2.29 - $2.52
Year range
$2.20 - $25.80
Market cap
107.93M USD
Avg Volume
302.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
119
